FindTrial
Sign In

Assessment of Cardiovascular outcomes in COVID-19 infected patients: A retrospective cohort study

Assessment of Cardiovascular outcomes in COVID-19 infected patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066066
Enrollment
212
Registered
2024-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients Above 18 Years or above are included in the study Patients with confirmed positive SARS-CoV-2 test result and existing cardiovascular disease hospitalized between 1st January 2021 to 31st December 2022

Exclusion criteria

Exclusion criteria: Incomplete patient data Patients who experienced mortality within 24 hours of admission

Design outcomes

Primary

MeasureTime frame
To study the cardiovascular Hospitalization/Mortality in COVID 19 patientsTimepoint: 3 OCTOBER 2023 TO 5 JULY 2025—

Secondary

MeasureTime frame
To assess the prevalence of Arterial thrombosis & venous thromboembolic events To study the cardiovascular drug utilization To study the drug interactionsTimepoint: 3 OCTOBER 2023 TO 5 JULY 2025—

Countries

India

Contacts

Public ContactVaishnavi Reghuprasad

Manipal College of Pharmaceutical Sciences

prasanna.shetty@manipal.edu9886725129

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026